MX9205714A - Compuesto farmaceutico y procedimiento para su obtencion - Google Patents
Compuesto farmaceutico y procedimiento para su obtencionInfo
- Publication number
- MX9205714A MX9205714A MX9205714A MX9205714A MX9205714A MX 9205714 A MX9205714 A MX 9205714A MX 9205714 A MX9205714 A MX 9205714A MX 9205714 A MX9205714 A MX 9205714A MX 9205714 A MX9205714 A MX 9205714A
- Authority
- MX
- Mexico
- Prior art keywords
- alkyl
- phenyl
- optionally substituted
- hydroxy
- carboxy
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 125000004185 ester group Chemical group 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 125000001624 naphthyl group Chemical group 0.000 abstract 2
- 150000002825 nitriles Chemical class 0.000 abstract 2
- -1 trifluoromethoxy, carboxy Chemical group 0.000 abstract 2
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 abstract 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919121358A GB9121358D0 (en) | 1991-10-09 | 1991-10-09 | Pharmaceutical compounds |
| GB929213058A GB9213058D0 (en) | 1992-06-19 | 1992-06-19 | Pharmaceutical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9205714A true MX9205714A (es) | 1993-04-01 |
Family
ID=26299655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9205714A MX9205714A (es) | 1991-10-09 | 1992-10-06 | Compuesto farmaceutico y procedimiento para su obtencion |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5284868A (es) |
| EP (1) | EP0537949B1 (es) |
| JP (1) | JPH05194477A (es) |
| KR (1) | KR100228841B1 (es) |
| CN (1) | CN1034938C (es) |
| AT (1) | ATE167859T1 (es) |
| AU (1) | AU658003B2 (es) |
| CA (1) | CA2079428A1 (es) |
| CZ (1) | CZ281688B6 (es) |
| DE (1) | DE69226060T2 (es) |
| DK (1) | DK0537949T3 (es) |
| ES (1) | ES2117035T3 (es) |
| FI (1) | FI924551A (es) |
| HU (1) | HU218916B (es) |
| IL (1) | IL103356A (es) |
| MX (1) | MX9205714A (es) |
| MY (1) | MY111368A (es) |
| NO (1) | NO301587B1 (es) |
| NZ (1) | NZ244627A (es) |
| PH (1) | PH30659A (es) |
| RU (1) | RU2071472C1 (es) |
| TW (1) | TW221292B (es) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9203497D0 (en) * | 1992-02-19 | 1992-04-08 | Lilly Industries Ltd | Pharmaceutical compounds |
| EP0599514A3 (en) * | 1992-11-18 | 1994-07-06 | Lilly Industries Ltd | Pyranoquinoline derivatives as inhibitors of cell proliferation. |
| GB9306062D0 (en) * | 1993-03-24 | 1993-05-12 | Lilly Industries Ltd | Pharmaceutical compounds |
| EP0619314A1 (en) * | 1993-04-09 | 1994-10-12 | Eli Lilly And Company | 4-Phenyl-4H- naphtho(2,1-b)pyran derivatives and their pharmaceutical use |
| WO1995008289A2 (en) * | 1993-09-16 | 1995-03-30 | Scimed Life Systems, Inc. | Percutaneous repair of cardiovascular anomalies and repair compositions |
| US5407955A (en) * | 1994-02-18 | 1995-04-18 | Eli Lilly And Company | Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease |
| US5665591A (en) * | 1994-12-06 | 1997-09-09 | Trustees Of Boston University | Regulation of smooth muscle cell proliferation |
| WO1997045105A1 (en) * | 1996-05-24 | 1997-12-04 | Angiotech Pharmaceuticals, Inc. | Compositions and methods for treating or preventing diseases of body passageways |
| IL119069A0 (en) * | 1996-08-14 | 1996-11-14 | Mor Research Applic Ltd | Pharmaceutical composition comprising tyrphostins |
| AU781986B2 (en) * | 1999-11-05 | 2005-06-23 | Cytovia, Inc. | Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| WO2002092076A1 (en) | 2001-05-16 | 2002-11-21 | Cytovia, Inc. | Substituted coumarins and quinolines as caspases activators |
| ATE450531T1 (de) * | 2001-05-16 | 2009-12-15 | Cytovia Inc | Substituierte 4h-chromene und analoga als aktivatoren von caspasen und induktoren von apoptose, und deren verwendung als antikrebsmittel |
| US6858607B1 (en) | 2001-05-16 | 2005-02-22 | Cytovia, Inc. | 7,8-fused 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| WO2003097806A2 (en) * | 2002-05-16 | 2003-11-27 | Cytovia, Inc. | Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| US7476741B2 (en) * | 2002-05-16 | 2009-01-13 | Cytovia, Inc. | Substituted 4H-chromens, 2H-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| US20040127519A1 (en) * | 2002-12-12 | 2004-07-01 | Pharmacia Corporation | Method of using aminocyanopyridine compounds as mitogen activated protein kinase-activated protein kinase-2 inhibitors |
| US20040127511A1 (en) * | 2002-12-12 | 2004-07-01 | Pharmacia Corporation | Tricyclic aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| EP1789079B1 (en) * | 2004-09-09 | 2012-11-07 | Howard Florey Institute Of Experimental Physiology And Medicine | Insulin-regulated aminopeptidase (IRAP) inhibitors and uses thereof |
| CA2770430A1 (en) * | 2005-02-16 | 2006-08-24 | Md Bioalpha Co., Ltd. | Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases |
| US20080183282A1 (en) * | 2006-03-09 | 2008-07-31 | Saul Yedgar | Use of lipid conjugates for the coating of stents and catheters |
| NZ585338A (en) * | 2007-11-19 | 2012-08-31 | Howard Florey Inst | Insulin-regulated aminopeptidase (irap) inhibitors and uses thereof |
| EA015364B1 (ru) * | 2009-03-18 | 2011-06-30 | Учреждение Российской Академии Наук Институт Элементоорганических Соединений Им. А.Н. Несмеянова Ран (Инэос Ран) | 6,6'-диизопропил-8,8'-диметил-2,2'-динитро-3,3'-бис(трифторметил)- 3н,3'н-[9,9']ди[бензо(f)хроменил]-5,10,5',10'-тетраол, обладающий противоопухолевой и противогрибковой активностью, и способ его получения |
| CN107235954A (zh) | 2010-11-12 | 2017-10-10 | 德国癌症研究中心 | 作为Wnt通路拮抗剂的色烯衍生物及其类似物 |
| CN104185631A (zh) * | 2011-11-10 | 2014-12-03 | 纪念斯隆-凯特琳癌症中心 | 用2-氨基-4H-萘并[1,2-b]吡喃-3-甲腈治疗卵巢癌 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU724509A1 (ru) * | 1978-09-21 | 1980-03-30 | Пермский государственный фармацевтический институт | Способ получени 2-ароил-3н- нафто 2,1-в пиранонов-3 |
| EP0412160A4 (en) * | 1988-04-14 | 1991-09-11 | Yamanouchi Pharmaceutical Co. Ltd. | Substance q-2819 and process for its preparation |
-
1992
- 1992-09-25 US US07/951,629 patent/US5284868A/en not_active Expired - Fee Related
- 1992-09-29 CA CA002079428A patent/CA2079428A1/en not_active Abandoned
- 1992-10-05 PH PH45043A patent/PH30659A/en unknown
- 1992-10-05 TW TW081107894A patent/TW221292B/zh active
- 1992-10-05 AU AU26216/92A patent/AU658003B2/en not_active Ceased
- 1992-10-05 CZ CS923035A patent/CZ281688B6/cs not_active IP Right Cessation
- 1992-10-05 IL IL103356A patent/IL103356A/en not_active IP Right Cessation
- 1992-10-06 RU SU925052861A patent/RU2071472C1/ru active
- 1992-10-06 NZ NZ244627A patent/NZ244627A/en unknown
- 1992-10-06 MX MX9205714A patent/MX9205714A/es not_active IP Right Cessation
- 1992-10-07 KR KR1019920018309A patent/KR100228841B1/ko not_active IP Right Cessation
- 1992-10-07 MY MYPI92001807A patent/MY111368A/en unknown
- 1992-10-08 CN CN92111625A patent/CN1034938C/zh not_active Expired - Fee Related
- 1992-10-08 EP EP92309169A patent/EP0537949B1/en not_active Expired - Lifetime
- 1992-10-08 HU HU9203183A patent/HU218916B/hu not_active IP Right Cessation
- 1992-10-08 JP JP4269002A patent/JPH05194477A/ja active Pending
- 1992-10-08 FI FI924551A patent/FI924551A/fi unknown
- 1992-10-08 NO NO923910A patent/NO301587B1/no not_active IP Right Cessation
- 1992-10-08 ES ES92309169T patent/ES2117035T3/es not_active Expired - Lifetime
- 1992-10-08 AT AT92309169T patent/ATE167859T1/de not_active IP Right Cessation
- 1992-10-08 DK DK92309169T patent/DK0537949T3/da active
- 1992-10-08 DE DE69226060T patent/DE69226060T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CZ281688B6 (cs) | 1996-12-11 |
| AU658003B2 (en) | 1995-03-30 |
| AU2621692A (en) | 1993-04-22 |
| JPH05194477A (ja) | 1993-08-03 |
| DK0537949T3 (da) | 1999-02-15 |
| NO923910D0 (no) | 1992-10-08 |
| NZ244627A (en) | 1994-12-22 |
| ATE167859T1 (de) | 1998-07-15 |
| ES2117035T3 (es) | 1998-08-01 |
| HU9203183D0 (en) | 1992-12-28 |
| RU2071472C1 (ru) | 1997-01-10 |
| CN1034938C (zh) | 1997-05-21 |
| PH30659A (en) | 1997-09-16 |
| NO301587B1 (no) | 1997-11-17 |
| US5284868A (en) | 1994-02-08 |
| DE69226060T2 (de) | 1998-11-19 |
| TW221292B (es) | 1994-02-21 |
| KR100228841B1 (ko) | 1999-11-01 |
| CA2079428A1 (en) | 1993-04-10 |
| IL103356A0 (en) | 1993-03-15 |
| HUT62281A (en) | 1993-04-28 |
| DE69226060D1 (de) | 1998-08-06 |
| HU218916B (hu) | 2000-12-28 |
| EP0537949A1 (en) | 1993-04-21 |
| FI924551A0 (fi) | 1992-10-08 |
| IL103356A (en) | 1998-02-22 |
| FI924551A (fi) | 1993-04-10 |
| MY111368A (en) | 1999-12-31 |
| EP0537949B1 (en) | 1998-07-01 |
| NO923910L (no) | 1993-04-13 |
| CN1073437A (zh) | 1993-06-23 |
| CZ303592A3 (en) | 1993-12-15 |
| KR930007931A (ko) | 1993-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9205714A (es) | Compuesto farmaceutico y procedimiento para su obtencion | |
| CO5150224A1 (es) | Compuestos de triazol y su utilizacion | |
| ES2077806T3 (es) | Derivados de isoxazol, procedimiento para su preparacion y sus aplicaciones herbicidas. | |
| ES2110421T3 (es) | O-bencil-oximeteres y los agentes protectores de las plantas que contienen estos compuestos. | |
| CO4970780A1 (es) | Nuevos compuestos heterociclicos de piridazina | |
| CO4970713A1 (es) | Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen | |
| DK0641325T3 (da) | Inhibitorer af retroviral protease | |
| DE69631865D1 (de) | Sulfonamide mit Elastase inhibierender Wirkung | |
| ES2036852T3 (es) | Procedimiento para la obtencion de trifluormetilfenil-azolilmetiloxiranos y su empleo como agentes protectores de las plantas. | |
| BR9307580A (pt) | Compostos processo para a preparação dos mesmos composições farmacêuticas uso de um composto e processo de tratamento de um mamífero que inclui o ser humano | |
| DOP2002000399A (es) | Nuevos derivados de acido sulfonico | |
| HRPK20040293B3 (en) | Substituted benzimidazole compounds and their use for the treatment of cancer | |
| MX9300840A (es) | Compuestos farmaceuticos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| DK0743938T3 (da) | Substituerede spiroforbindelser til behandling af inflammation | |
| ATE167855T1 (de) | Propensäure derivate verwendbar als fungizide | |
| DK0639173T3 (da) | Visse 2- (2'-methyl-3', 4'-trisubstitueret benzoyl) -1,3-cyklohexandioner | |
| ATE236901T1 (de) | Herbizide substituierte thienocycloalk(en)ylamino-1,3,5-triazine | |
| ID24231A (id) | Derivat-derivat 5-disubstitusi-1,2,4-tiadiazolil yang menghambat angiogenesis | |
| ES8303438A1 (es) | Un procedimiento para la preparacion de perfluoroamidas | |
| NZ214980A (en) | 5-sulphonamido-1-arylpyrazoles and herbicidal compositions | |
| MX9204939A (es) | Inhibidores 5-bis-aminometilen-1,3-dioxan-4,6-diona n,n',n'-trisubstituidas, de la acil coenzima a: colesterol-aciltransferasa. | |
| CO5210866A1 (es) | Inhibidores de cinasas, de pirrolotriazina | |
| TH17774A (th) | อนุพันธ์ 1,3-ออกซาซิน-4-โอนชนิดใหม่ สารฆ่าวัชพืชที่มีอนุพันธ์เหล่านี้และสารมัธยันตร์สำหรับการเตรียอนุพันธ์เหล่านี้ | |
| TH17774EX (th) | อนุพันธ์ 1,3-ออกซาซิน-4-โอนชนิดใหม่ สารฆ่าวัชพืชที่มีอนุพันธ์เหล่านี้และสารมัธยันตร์สำหรับการเตรียอนุพันธ์เหล่านี้ | |
| TH23895A (th) | ซับสทิทิวเทด 2-เฟนิลพิริดีน |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |